Short Term Group Therapy for Anxiety Disorder

This study has been completed.
Sponsor:
Information provided by:
Sheba Medical Center
ClinicalTrials.gov Identifier:
NCT00229281
First received: September 28, 2005
Last updated: December 18, 2007
Last verified: December 2007
  Purpose

Assessing Anxiety in patient suffering from anxiety disorders (NOT OCD or PTSD)before and after group therapy


Condition Intervention
Anxiety Disorder
Behavioral: Group therapy

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment

Resource links provided by NLM:


Further study details as provided by Sheba Medical Center:

Estimated Enrollment: 30
Study Start Date: February 2004
  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Anxiety disorder (other than OCD or PTSD)
  • Eligibility to participate in group therapy

Exclusion Criteria:

  • OCD
  • PTSD
  • Suicidal thoughts
  • Psychotic state
  • Severe hostile personality disorder
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00229281

Locations
Israel
Chaim Sheba Medical Center
Ramat-Gan, Israel, 52621
Sponsors and Collaborators
Sheba Medical Center
Investigators
Principal Investigator: Joseph Zohar, MD Tel Aviv University
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00229281     History of Changes
Other Study ID Numbers: SHEBA-05-3680-JZ-CTIL
Study First Received: September 28, 2005
Last Updated: December 18, 2007
Health Authority: Israel: Israeli Health Ministry Pharmaceutical Administration

Additional relevant MeSH terms:
Anxiety Disorders
Mental Disorders

ClinicalTrials.gov processed this record on April 17, 2014